Logo image of AXR

AMREP CORP (AXR) Stock Fundamental Analysis

NYSE:AXR - New York Stock Exchange, Inc. - US0321591051 - Common Stock - Currency: USD

31.27  +0.23 (+0.74%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to AXR. AXR was compared to 63 industry peers in the Real Estate Management & Development industry. AXR gets an excellent profitability rating and is at the same time showing great financial health properties. AXR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year AXR was profitable.
AXR had a positive operating cash flow in the past year.
AXR had positive earnings in 4 of the past 5 years.
AXR had a positive operating cash flow in each of the past 5 years.
AXR Yearly Net Income VS EBIT VS OCF VS FCFAXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

With an excellent Return On Assets value of 9.56%, AXR belongs to the best of the industry, outperforming 94.92% of the companies in the same industry.
With an excellent Return On Equity value of 9.87%, AXR belongs to the best of the industry, outperforming 88.14% of the companies in the same industry.
With an excellent Return On Invested Capital value of 8.04%, AXR belongs to the best of the industry, outperforming 94.92% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AXR is significantly above the industry average of 4.79%.
Industry RankSector Rank
ROA 9.56%
ROE 9.87%
ROIC 8.04%
ROA(3y)13.67%
ROA(5y)8.5%
ROE(3y)14.81%
ROE(5y)9.15%
ROIC(3y)11.51%
ROIC(5y)N/A
AXR Yearly ROA, ROE, ROICAXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

With an excellent Profit Margin value of 19.52%, AXR belongs to the best of the industry, outperforming 93.22% of the companies in the same industry.
In the last couple of years the Profit Margin of AXR has grown nicely.
AXR's Operating Margin of 20.03% is amongst the best of the industry. AXR outperforms 88.14% of its industry peers.
In the last couple of years the Operating Margin of AXR has declined.
With a Gross Margin value of 31.43%, AXR perfoms like the industry average, outperforming 54.24% of the companies in the same industry.
In the last couple of years the Gross Margin of AXR has grown nicely.
Industry RankSector Rank
OM 20.03%
PM (TTM) 19.52%
GM 31.43%
OM growth 3Y-12.96%
OM growth 5YN/A
PM growth 3Y-10.97%
PM growth 5Y2.13%
GM growth 3Y-7.98%
GM growth 5Y29.24%
AXR Yearly Profit, Operating, Gross MarginsAXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AXR is creating some value.
AXR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, AXR has less shares outstanding
AXR has a worse debt/assets ratio than last year.
AXR Yearly Shares OutstandingAXR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
AXR Yearly Total Debt VS Total AssetsAXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

AXR has an Altman-Z score of 27.33. This indicates that AXR is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 27.33, AXR belongs to the best of the industry, outperforming 96.61% of the companies in the same industry.
The Debt to FCF ratio of AXR is 0.00, which is an excellent value as it means it would take AXR, only 0.00 years of fcf income to pay off all of its debts.
AXR has a Debt to FCF ratio of 0.00. This is amongst the best in the industry. AXR outperforms 93.22% of its industry peers.
AXR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, AXR belongs to the top of the industry, outperforming 84.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 27.33
ROIC/WACC0.88
WACC9.16%
AXR Yearly LT Debt VS Equity VS FCFAXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.3 Liquidity

AXR has a Current Ratio of 26.03. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
AXR's Current ratio of 26.03 is amongst the best of the industry. AXR outperforms 98.31% of its industry peers.
A Quick Ratio of 10.09 indicates that AXR has no problem at all paying its short term obligations.
AXR's Quick ratio of 10.09 is amongst the best of the industry. AXR outperforms 96.61% of its industry peers.
Industry RankSector Rank
Current Ratio 26.03
Quick Ratio 10.09
AXR Yearly Current Assets VS Current LiabilitesAXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for AXR have decreased strongly by -34.60% in the last year.
Measured over the past years, AXR shows a very strong growth in Earnings Per Share. The EPS has been growing by 47.37% on average per year.
Looking at the last year, AXR shows a very strong growth in Revenue. The Revenue has grown by 54.35%.
The Revenue has been growing by 32.04% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-34.6%
EPS 3Y9.61%
EPS 5Y47.37%
EPS Q2Q%258.16%
Revenue 1Y (TTM)54.35%
Revenue growth 3Y8.61%
Revenue growth 5Y32.04%
Sales Q2Q%34.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AXR Yearly Revenue VS EstimatesAXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AXR Yearly EPS VS EstimatesAXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.60 indicates a correct valuation of AXR.
AXR's Price/Earnings ratio is rather cheap when compared to the industry. AXR is cheaper than 88.14% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.58. AXR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.6
Fwd PE N/A
AXR Price Earnings VS Forward Price EarningsAXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

AXR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AXR is cheaper than 91.53% of the companies in the same industry.
AXR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AXR is cheaper than 93.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.75
EV/EBITDA 9.67
AXR Per share dataAXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

AXR has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.29
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AXR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMREP CORP

NYSE:AXR (2/5/2025, 8:04:00 PM)

31.27

+0.23 (+0.74%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)12-10 2024-12-10/amc
Earnings (Next)03-06 2025-03-06
Inst Owners38.13%
Inst Owner Change1.68%
Ins Owners44.9%
Ins Owner Change0.94%
Market Cap165.42M
Analysts0
Price TargetN/A
Short Float %0.86%
Short Ratio0.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.6
Fwd PE N/A
P/S 2.62
P/FCF 8.75
P/OCF 8.55
P/B 1.32
P/tB 1.32
EV/EBITDA 9.67
EPS(TTM)2.3
EY7.36%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.58
FCFY11.43%
OCF(TTM)3.66
OCFY11.7%
SpS11.95
BVpS23.64
TBVpS23.64
PEG (NY)N/A
PEG (5Y)0.29
Profitability
Industry RankSector Rank
ROA 9.56%
ROE 9.87%
ROCE 10.12%
ROIC 8.04%
ROICexc 11.83%
ROICexgc 11.88%
OM 20.03%
PM (TTM) 19.52%
GM 31.43%
FCFM 29.92%
ROA(3y)13.67%
ROA(5y)8.5%
ROE(3y)14.81%
ROE(5y)9.15%
ROIC(3y)11.51%
ROIC(5y)N/A
ROICexc(3y)14.28%
ROICexc(5y)N/A
ROICexgc(3y)14.32%
ROICexgc(5y)N/A
ROCE(3y)14.5%
ROCE(5y)N/A
ROICexcg growth 3Y-13.41%
ROICexcg growth 5YN/A
ROICexc growth 3Y-13.43%
ROICexc growth 5YN/A
OM growth 3Y-12.96%
OM growth 5YN/A
PM growth 3Y-10.97%
PM growth 5Y2.13%
GM growth 3Y-7.98%
GM growth 5Y29.24%
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 261.54%
Cap/Sales 0.7%
Interest Coverage 250
Cash Conversion 150.83%
Profit Quality 153.25%
Current Ratio 26.03
Quick Ratio 10.09
Altman-Z 27.33
F-Score6
WACC9.16%
ROIC/WACC0.88
Cap/Depr(3y)361.42%
Cap/Depr(5y)217.58%
Cap/Sales(3y)1.12%
Cap/Sales(5y)0.68%
Profit Quality(3y)90.43%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.6%
EPS 3Y9.61%
EPS 5Y47.37%
EPS Q2Q%258.16%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)54.35%
Revenue growth 3Y8.61%
Revenue growth 5Y32.04%
Sales Q2Q%34.47%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.84%
EBIT growth 3Y-5.47%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.16%
FCF growth 3Y-6.63%
FCF growth 5Y77.63%
OCF growth 1Y66.69%
OCF growth 3Y-5.29%
OCF growth 5Y78.57%